The use of nasal decongestants to correction the respiratory and olfactory function of the nose
https://doi.org/10.21518/2079-701X-2019-8-60-65
Abstract
One of the main functions of the nose is respiratory and olfactory. Difficulty in nasal breathing, nasal congestion, nasal discharge can complicate the respiratory and olfactory functions of the nose or make them impossible. Most often the cause is swelling of the mucous. Nasal obstruction and rhinorrhea are the most common symptoms in diseases of the nasal cavity and paranasal sinuses. Of great importance is the use of local vasoconstrictors to eliminate swelling in the nasal cavity and prevent complications associated with auditory tube dysfunction. It is proved that the use of nasal decongestants helps to reduce swelling in the nasal cavity and in the osteomeatal complex. Otrivin Moisturizing formula, Otrivin Menthol, Otrivin Complex and Otrivin Sea are effective and well tolerated means to eliminate swelling in the nasal cavity and reduce nasal discharge and rehabilitation of olfactory function.
About the Authors
S. V. Morozova
Federal State Autonomous Educational Institution of Higher Education First Moscow State Medical University named after I.M. Sechenov of
the Ministry of Health of the Russian Federation (Sechenov University)
Russian Federation
Dr. of Sci. (Med.), Professor of Chair for Ear, Nose and Throat Diseases, Federal State Autonomous Educational Institution of Higher Education «Sechenov First Moscow State Medical University» of the Ministry of Heath of the Russian Federation (Sechenov University)
Russian Federation
Dr. of Sci. (Med.), Professor of Chair for Ear, Nose and Throat Diseases, Federal State Autonomous Educational Institution of Higher Education «Sechenov First Moscow State Medical University» of the Ministry of Heath of the Russian Federation (Sechenov University)
L. A. Toporkova
Federal State Autonomous Educational Institution of Higher Education First Moscow State Medical University named after I.M. Sechenov of
the Ministry of Health of the Russian Federation (Sechenov University)
Russian Federation
a postgraduate student of Chair for Ear, Nose and Throat Diseases, Federal State Autonomous Educational Institution of Higher Education «Sechenov First Moscow State Medical University» of the Ministry of Heath of the Russian Federation (Sechenov University)
Russian Federation
a postgraduate student of Chair for Ear, Nose and Throat Diseases, Federal State Autonomous Educational Institution of Higher Education «Sechenov First Moscow State Medical University» of the Ministry of Heath of the Russian Federation (Sechenov University)
References
1. Piskunov G.Z. Physiology and pathophysiology of the nose and paranasal sinuses. Rossijskaja rinologiya. 2017;25(3):51-57. doi: 10.17116/rosrino201725351-57.] (In Russ.)
2. Hummel T. et. al. EPOS. Supplement 26 Olfactory dysfunctions. 2017, p. 6.
3. European Position Paper on Rhinosinusitis and Nasal Polyps 2012. Rhinology supplement. 2012;23:1-298,
4. Acute sinusitis. Clinical guidelines. National medical Association of otolaryngologists. 2016:3-25.] (In Russ.)
5. Svistushkin V.M., Slavsky A.N., Pshonkina D.M. Bacteriophages in the complex treatment of acute bacterial rhinosinusitis. RMG. 2014;26:19-25.] (In Russ.)
6. Onerci T.M. Diagnosis in otorhinolaryngology, Springer-Verlag Berlin Heidelberg. 2009: 60-65.
7. Dunnebier E.A. Radiodiagnostics. Otorhinolaryngology. Medpress-inform, 2013:202-213.] (In Russ.)
8. Svistushkin V.M., Toporkova L.A. National guidelines for the treatment of patients with acute respiratory infections of the upper respiratory tract: what is important to know the therapist? Pharmateca. 2017:2-17.] (In Russ.)
9. Pharmacotherapy of purulent inflammatory pathology of ENT organs. Under the editorship of A.I. Kryukov. Moscow, 2018:1-30.] (In Russ.)
10. Sahin G. Nitric oxide: a promising methodological approach in airway diseases. Int Arch Allergy Immunol. 2011;156(4):352-61
11. Palchun V.T. Otorhinolaryngology. National leadership. M.: GEOTAR-media. 2009:626-762.] (In Russ.)
12. Morozova S.V. Prevention of complications of acute infectious rhinitis in children. RMG. 2014;3:198-202.] (In Russ.)
13. Stringer S.P., Mancuso A.A., Avino A.J. Effect of a topical vasoconstrictor on computed tomography of paranasal sinus disease. The Laryngoscope. 1993;103(1 Pt 1):6-9
14. Benammar-Englmaier M., Hallermeier J.K., Englmaier B. Alphamimetic effects on nasal mucosa in magnetic resonance tomography. Digitale Bild Diagn. 1990;10(2):46-50
15. Westerveld G.J., Voss H.P., van der Hee R.M., de Haan-Koelewijn G.J., den Hartog G.J., Scheeren R.A., et al. Inhibition of nitric oxide synthase by nasal decongestants. The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology. 2000;16(3):437-44
16. Wester veld G.J., Scheeren R.A., Dekker I., Griffioen D.H., Voss H.P., Bast A. Anti-oxidant actions of oxymethazoline and xylomethazoline. Eur J Pharmacol. 1995;291(1):27-31
17. Pneumatikos I., Konstantonis D., Dragoumanis C., Danielides V., Bouros D. Preventing nosocomial sinusitis in the ICU: Reply to van Zanten et al. Intensive Care Medicine. 2006;32(9):1452-3.
18. Instructions for use of the medical drug Otrivin Moisturizing formula. http://www.otrivin.ru/products/otrivinuvlazhnyayuschaya-formula-instruktsiya.html. Accessed 15.03.19.] (In Russ.)
19. Eccles R. et al. The nasal decongestant effect of xylometazoline in the common cold. American Journal of Rhinology. 2008 September-October;22(5):495
20. Instructions for use of the drug Otrivin Complex. http://www.otrivin.ru/products/otrivin-uvlazhnyayuschaya-formula-instruktsiya. html. Accessed 15.03.19.] (In Russ.)
21. Eccles R., Martensson K. & Chen Sh.C. Effects of intranasal xylometazoline, alone or in combination with ipratropium, in patients with common cold. Current Medical Research and Opinion. 2010; 26(4):889-899. Doi: 10.1185/03007991003648015.
22. Hayden F.G., Diamond L., Wood P.B., Korts D.C., Wecker M.T. Effectiveness and Safety of Intranasal Ipratropium Bromide in Common Colds: A Randomized, Double-Blind, Placebo-Controlled Trial. Ann Intern Med.1996;125:89–97. doi: 10.7326/0003-4819-125-2-199607150-00002.
Review
For citations:
Morozova SV, Toporkova LA. The use of nasal decongestants to correction the respiratory and olfactory function of the nose. Meditsinskiy sovet = Medical Council. 2019;(8):60-65. (In Russ.) https://doi.org/10.21518/2079-701X-2019-8-60-65
Views:
1060
Email this article 